Skip to main content
Equibles

Invesco Ltd.

Position in FATE — Fate Therapeutics Inc

CIK 914208 Atlanta, GA
Back to FATE Full portfolio

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$718,151
+$267,088 QoQ
Shares Held
265,982
-29.2% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. FATE ranks #168 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in FATE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $718,151 265,982
2026-03-31 $451,063 375,886
2025-12-31 $371,443 379,025
2025-09-30 $396,678 314,825
2025-06-30 $286,014 255,372
2025-03-31 $168,665 213,503
2024-12-31 $179,739 108,934
2024-09-30 $356,572 101,878
2024-06-30 $334,873 102,096
2024-03-31 $7,086,263 965,431
2023-12-31 $484,157 129,454
2023-09-30 $266,243 125,587
2023-06-30 $565,467 118,796
2023-03-31 $702,586 123,261
2022-12-31 $479,061 47,479
2022-09-30 $1,146,628 51,166
2022-06-30 $1,178,288 47,550
2022-03-31 $39,356,084 1,015,117
2021-12-31 $51,680,652 883,279
2021-09-30 $7,138,891 120,447
2021-06-30 $76,733,987 884,134
2021-03-31 $55,829,862 677,136
2020-12-31 $38,541,225 423,856
2020-09-30 $12,852,233 321,547
2020-06-30 $849,995 24,774
2020-03-31 $3,275,130 147,462